 | Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Short Interest Up 8.5% in June
www.americanbankingnews.com - July 8 at 5:01 AM |
 | Should You Buy Lexicon Pharmaceuticals, Inc. (LXRX)?
finance.yahoo.com - July 4 at 7:04 PM |
| Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - June 26 at 1:17 AM |
| Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Expected to Announce Quarterly Sales of $8.70 Million
www.americanbankingnews.com - June 22 at 9:08 AM |
| Brokerages Expect Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) to Post -$0.57 Earnings Per Share
www.americanbankingnews.com - June 20 at 9:53 AM |
| Lexicon Pharmaceuticals Announces Preclinical Efficacy Data on Telotristat Ethyl’s Antiproliferative Effects Against Various Cancer Cell Lines
finance.yahoo.com - May 13 at 6:11 PM |
| Edited Transcript of LXRX earnings conference call or presentation 27-Apr-20 12:00pm GMT
finance.yahoo.com - May 2 at 1:12 AM |
 | Why Lexicon Pharmaceuticals Stock Soared Today
www.fool.com - April 27 at 7:59 PM |
 | Lexicon Pharmaceuticals Inc (LXRX) Q1 2020 Earnings Call Transcript
www.nasdaq.com - April 27 at 2:58 PM |
 | Lexicon Pharmaceuticals EPS beats by $0.05, beats on revenue
seekingalpha.com - April 27 at 9:57 AM |
|
| Lexicon Pharma Xermelo sales up 17% in Q1
seekingalpha.com - April 27 at 9:57 AM |
| LEXICON PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE
finance.yahoo.com - April 27 at 9:57 AM |
| Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - April 27 at 9:57 AM |
 | Lexicon Pharmaceuticals: Q1 Earnings Insights
feeds.benzinga.com - April 27 at 7:55 AM |
| Lexicon Pharmaceuticals to Host First Quarter 2020 Financial Results Conference Call and Webcast On April 27, 2020
finance.yahoo.com - April 22 at 7:24 PM |
| The Lexicon Pharmaceuticals (NASDAQ:LXRX) Share Price Is Down 88% So Some Shareholders Are Rather Upset
finance.yahoo.com - April 20 at 2:10 PM |
 | Lexicon Pharmaceuticals Inc
www.bloomberg.com - April 18 at 6:53 PM |
| LEXICON PHARMACEUTICALS TO HOST VIRTUAL ANNUAL MEETING OF STOCKHOLDERS ON APRIL 23, 2020
finance.yahoo.com - April 7 at 5:53 PM |
| Lexicon Pharmaceuticals Moving On From Diabetes And Pivoting Toward Clinical Candidates
seekingalpha.com - March 24 at 1:25 PM |
| Mylan's COVID-19 Medicine, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - March 22 at 8:11 AM |
| Lexicon shuts down two Zynquista studies due to funding issues
seekingalpha.com - March 19 at 6:33 PM |
| LEXICON PHARMACEUTICALS PROVIDES AN UPDATE ON THE SOTAGLIFLOZIN TYPE 2 DIABETES PROGRAM
finance.yahoo.com - March 19 at 6:33 PM |
| LEXICON PHARMACEUTICALS ANNOUNCES ADDITIONAL DATA ON TELOTRISTAT ETHYL'S ANTIPROLIFERATIVE EFFECTS IN PATIENTS WITH CARCINOID SYNDROME
www.benzinga.com - March 15 at 5:36 PM |
| Lexicon Pharma up 11% premarket on positive Xermelo data
seekingalpha.com - March 13 at 1:46 PM |
| LEXICON PHARMACEUTICALS ANNOUNCES ADDITIONAL DATA ON TELOTRISTAT ETHYL’S ANTIPROLIFERATIVE EFFECTS IN PATIENTS WITH CARCINOID SYNDROME
finance.yahoo.com - March 13 at 8:45 AM |
| Edited Transcript of LXRX earnings conference call or presentation 12-Mar-20 12:00pm GMT
finance.yahoo.com - March 12 at 11:53 PM |
| Lexicon Pharmaceuticals: Q4 Earnings Insights
finance.yahoo.com - March 12 at 6:53 PM |
| Lexicon Pharmaceuticals (LXRX) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - March 12 at 1:52 PM |
| Lexicon Pharmaceuticals EPS beats by $0.29, misses on revenue
seekingalpha.com - March 12 at 8:52 AM |
| LEXICON PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE
finance.yahoo.com - March 12 at 8:52 AM |
|
| Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2019 Financial Results Conference Call and Webcast on March 12, 2020
finance.yahoo.com - March 5 at 10:40 AM |
| Analysts Estimate Lexicon Pharmaceuticals (LXRX) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - March 4 at 1:41 PM |
| Lexicon Pharmaceuticals Announces Real-World Data on Telotristat Ethyl’s Antiproliferative Effects in Patients With Carcinoid Syndrome
finance.yahoo.com - January 24 at 3:42 PM |
| Lexicon Pharmaceuticals Announces Poster Presentation at the ASCO 2020 Gastrointestinal Cancers Symposium
www.benzinga.com - January 20 at 5:01 PM |
| Is Lexicon Pharmaceuticals (NASDAQ:LXRX) Using Too Much Debt?
finance.yahoo.com - January 20 at 10:11 AM |
| Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
www.benzinga.com - January 6 at 7:45 PM |
| Lexicon Needs More Than Incremental Positive Clinical Data
seekingalpha.com - December 20 at 2:14 PM |
| Lexicon Pharma's Zynquista successful in late-stage T2D study; shares up 16% PM
seekingalpha.com - December 20 at 9:14 AM |
| Lexicon shares fall on diabetes study data
finance.yahoo.com - December 20 at 9:14 AM |
| Implied Volatility Surging for Lexicon (LXRX) Stock Options
finance.yahoo.com - December 13 at 1:48 PM |
| Lexicon up 4% on positive early-stage data on neuropathic pain candidate LX9211
seekingalpha.com - December 5 at 1:22 PM |
| How Much is Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX) CEO Getting Paid?
finance.yahoo.com - December 5 at 1:22 PM |
| Lexicon Pharmaceuticals Announces Positive Topline Phase 1 Data for LX9211
finance.yahoo.com - December 5 at 8:22 AM |
| Lexicon Pharma up 6% on advancement of biliary cancer candidate
seekingalpha.com - December 3 at 1:47 PM |
| Lexicon Pharmaceuticals Completes Safety Review of Initial Safety Run-in Cohort of TELE-ABC Study, a Phase 2 Clinical Study of Telotristat Ethyl in Biliary Tract Cancer
finance.yahoo.com - December 3 at 8:46 AM |
| Why Roku, Ollie's Bargain Outlet Holdings, and Lexicon Pharmaceuticals Slumped Today
www.fool.com - December 2 at 5:12 PM |
| LXRX, APA among premarket losers
seekingalpha.com - December 2 at 12:09 PM |
| Here's Why Lexicon Pharmaceuticals Is Tumbling Today
www.fool.com - December 2 at 12:09 PM |
| Lexicon loses appeal of sotagliflozin CRL; shares down 10% premarket
seekingalpha.com - December 2 at 12:09 PM |
| Lexicon Pharma shares plummet after FDA denies appeal against drug rejection
www.nasdaq.com - December 2 at 12:09 PM |
